Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities?

Bone and Joint Journal

Volumn 96B, Issue 10, 2014, Pages 1396-1403

  Salunke, A A ^a   Chen, Y ^a   Tan, J H ^a   Chen, X ^a   Khin, L W ^b   Puhaindran, M E ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; LIMB AMPUTATION; LIMB SALVAGE; META ANALYSIS (TOPIC); OSTEOSARCOMA; PATHOLOGIC FRACTURE; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; BONE NEOPLASMS; COMPLICATION; FRACTURES, SPONTANEOUS; HEALTH; INCIDENCE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS; SURVIVAL RATE; TRENDS;

BONE NEOPLASMS; COMBINED MODALITY THERAPY; FRACTURES, SPONTANEOUS; GLOBAL HEALTH; HUMANS; INCIDENCE; OSTEOSARCOMA; PROGNOSIS; SURVIVAL RATE;

EID: 84907509118     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.96B10.34370     Document Type: Review

References (42)

1. Glass AG, Fraumeni JF Jr. Epidemiology of bone cancer in children. J Natl Cancer Inst 1970;44-1:187-199.
2. Abudu A, Sferopoulos NK, Tillman RM, Carter SR, Grimer RJ. The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg [Br] 1996;78-B:694-698.
3. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009;152:3-13.
4. Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006;106-5:1154-1161.
5. Coley BL, Pool JL. Factors Influencing the Prognosis in Osteogenic Sarcoma. Ann Surg 1940;112-6:1114-1128.
6. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121- 145.
7. Scully SP, Temple HT, O'Keefe RJ, Mankin HJ, Gebhardt M. The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop Relat Res 1996;324-227.
8. Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC. Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg [Am] 2002;84-A:49-57.
9. Ebeid W, Amin S, Abdelmegid A. Limb salvage management of pathologic fractures of primary malignant bone tumors. Cancer Control 2005;12:57-61.
10. Jaffe N, Spears R, Eftekhari F, et al. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival. Cancer 1987;59:701-709.
11. Bacci G, Ferrari S, Longhi A, et al. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 2003;74:449-454.
12. Jeon DG, Lee SY, Kim JW. Bone primary sarcomas undergone unplanned intralesional procedures - The possibility of limb salvage and their oncologic results. J Surg Oncol 2006;94:592-598.
13. Ferrari S PE. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol 2007;19:341-346.
14. Sarahrudi K HK, Heinz T, Millington S, Vécsei V. Treatment results of pathological fractures of the long bones: A retrospective analysis of 88 patients. Int Orthop 2006;6:519-524.
15. Anract P, Tomeno B, Forest M. Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature. Rev Chir Orthop Reparatrice Appar Mot 1994;80:669-680 (in French).
16. Kropej D SC, Ritschl P, Salzer-Kuntschik M, Kotz R. The management of IIB osteosarcoma. Experience from 1976-1985. Clin Orthop Relat Res 1991;270:40-44.
17. Bramer JA, Abudu AA, Grimer RJ, Carter SR, Tillman RM. Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 2007;43:1944-1951.
18. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg [Am] 2005;87-A:2822.
19. Zeifang F, Sabo D, Ewerbeck V. Pathological fracture in primary malignant bone tumors. Chirurg 2000;71:1121-1125 (in German).
20. Moradi B, Zahlten-Hinguranage A, Lehner B, Zeifang F. The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours. Int Orthop 2010;34:1017-1023.
21. Zuo D, Zheng L, Sun W, Hua Y, Cai Z. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: A case-control study. World J Surg Oncol 2013;11:148.
22. Xie L, Guo W, Li Y, Ji T, Sun X. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins. J Surg Oncol 2012;106-7:820-825.
23. Grimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol 2005;6:85-92.
24. Ferguson PC, McLaughlin CE, Griffin AM, et al. Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma. J Surg Oncol 2010;102:120-124.
25. Yin K, Liao Q, Zhong D, et al. Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture. Exp Ther Med 2012;4:889-894.
26. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:1-34.
27. Wells GA SB, O'Connell D, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp (date last accessed 8 July 2014).
28. Kim MS, Lee SY, Lee TR, et al. Prognostic effect of pathologic fracture in localized osteosarcoma: A cohort/case controlled study at a single institute. J Surg Oncol 2009;100:233-239.
29. Cho WH, Song WS, Jeon DG, et al. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations. Ann Surg Oncol 2010;17:702-708.
30. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121- 145.
31. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
32. Jawad MU, Scully SP. In brief: classifications in brief: Enneking classification: benign and malignant tumors of the musculoskeletal system. Clin Orthop Relat Res 2010;468:2000-2002.
33. No authors listed. AJCC Cancer Staging Manual. Sixth ed, Springer, 2002:213-219.
34. Chandrasekar CR, Grimer RJ, Carter SR, et al. Pathological fracture of the proximal femur in osteosarcoma: need for early radical surgery? ISRN Oncol 2012;2012:512389.
35. Natarajan MV, Govardhan RH, Williams S, Raja Gopal TS. Limb salvage surgery for pathological fractures in osteosarcoma. Int Orthop 2000;24:170-172.
36. Finn HA, Simon MA. Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals. Clin Orthop Relat Res 1991;262:108-118.
37. Longhi A EC, DePaolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006;32:423-436.
38. Cui Q LD, Liu C, Guo J, et al. Two case-reports of the limb salvage treatment of osteosarcoma consolidated with obvious pathological fractures. Pathol Oncol Res 2011;17:973-979.
39. Godley K, Watts AC, Robb JE. Pathological femoral fracture caused by primary bone tumour: A population-based study. Scott Med J 2011;56:5-9.
40. Thompson RC Jr, Pritchard DJ, Nelson TE. Pathologic fractures in osteosarcoma. J Bone Joint Surg [Br] 1992;74-B(SupplIII):277.
41. Yin K, Liao Q, Zhong D, et al. Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture. Exp Ther Med.2012;4:889-894.
42. Kim MS, Lee SY, Cho WH, et al. Prognostic effects of doctor-associated diagnostic delays in osteosarcoma. Arch Orthop Trauma Surg 2009;129:1421-1425.